治疗慢性阻塞性肺病的分子方法:当前前景和未来方向
Sheryl-Phuc Vu1, Kaleb Veit1, Ruxana T Sadikot1,2,3
1Division of Pulmonary, Critical Care & Sleep, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA.
International journal of molecular sciences
|March 13, 2025
概括
慢性阻塞性肺病 (COPD) 涉及肺炎和氧化应激. 本综述探讨了开发COPD新型治疗方法的分子策略,解决了这个日益增长的全球健康挑战的有限治疗选择.
科学领域:
- 肺部医学 肺部医学
- 分子生物学分子生物学
- 病变发生学研究 病变发生学研究
背景情况:
- 慢性阻塞性肺病 (COPD) 的特点是空气流量限制和肺部膨胀.
- 它源于由于暴露于有害颗粒/气体,如香烟烟雾等的慢性呼吸道炎症.
- 慢性肺炎涉及持续的炎症和氧化应激,恶化后恶化,全球患病率和死亡率上升.
研究的目的:
- 审查用于开发COPD新型治疗方法的分子方法.
- 为了解决分子治疗发展的滞后,尽管人们对COPD病变的理解越来越大.
- 突出未来COPD治疗的潜在策略.
主要方法:
- 关于COPD分子机制的文献综述.
- 对有关新型治疗点的当前研究进行分析.
- 综合了关于COPD治疗分子方法的发现.
主要成果:
- 对COPD病原体的理解有了显著的进步.
- 新型疗法开发的分子方法已经落后.
- 几条分子通路呈现出潜在的治疗点.
结论:
- 分子策略为新型COPD疗法提供了有希望的途径.
- 对这些分子方法的进一步研究对于有效治疗至关重要.
- 准分子途径可以减轻COPD的进展并改善患者的治疗结果.
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
COPD: Pathogenesis and Clinical Features
223
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
223


